Jupiter Neurosciences, Inc. (JUNS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 35.32M |
| Enterprise Value | 36.85M |
| P/E Ratio | -0.13 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 18.28 |
| Price/Book Ratio | -3.72 |
| Enterprise/Revenue | 21.79 |
| Enterprise/EBITDA | -0.15 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -142.2 |
| Operating Margin | -151.67 |
| Return On Assets | -2.47 |
| Return On Equity | 7.47 |
| Revenue | 21,796 |
| Revenue/Share | 0.12 |
| Gross Profit | 17,565 |
| EBITDA | -8.58M |
| Net Income | -8.64M |
| Diluted EPS | -18.75 |
| Total Cash | 1.52M |
| Total Cash/Share | 2.73 |
| Total Debt | 1.75M |
| Total Debt/Equity | -4.78 |
| Current Ratio | 0.66 |
| Book Value Per Share | -0.66 |
| 52-Week Change | -98.09 |
| 52-Week High | 135.75 |
| 52-Week Low | 2.38 |
| Moving Average 50 Days | 5.15 |
| Moving Average 200 Days | 29.44 |
| Average Volume | 999,268 |
| Shares Outstanding | 484,666 |
| % Held by Institutions | 3 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:75 |
| Last Split Date | August 07, 2026 |